back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-12 11:24 Tx date 2023-05-08 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
325,000 | |
| Filed 2023-01-30 08:40 Tx date 2023-01-26 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
| Filed 2023-01-19 19:46 Tx date 2023-01-17 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$19,333
+214,815 vol $0.09 each |
314,815 | |
| Filed 2023-01-03 13:42 Tx date 2022-12-30 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
50,000 | |
| Filed 2023-01-03 13:41 Tx date 2021-06-01 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-03 13:41 Tx date 2022-12-30 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2021-06-18 18:04 Tx date 2021-06-15 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+150,000 vol $0.40 each |
150,000 | |
| Filed 2021-06-18 18:04 Tx date 2021-06-01 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-18 18:03 Tx date 2021-06-01 |
$RP
RepliCel Life Sciences Inc. |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-01 Tx date 2018-03-08 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-01 Tx date 2018-03-14 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2018-04-01 Tx date 2018-03-08 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-01 Tx date 2018-03-14 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-01 Tx date 2018-03-08 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-29 Tx date 2018-03-08 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2018-03-29 Tx date 2018-03-14 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-19 Tx date 2018-03-14 |
$NETC
GAR Limited |
Boddington, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 |